nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
B cell depletion in infants after intra uterine exposure to immunomodulating chemotherapy with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP): A case series and review of the literature
|
Wieringa, Jantien W. |
|
|
4 |
C |
p. 1-6 |
artikel |
2 |
Challenges in the diagnosis and management of SLE in India
|
Chatterjee, Rudrarpan |
|
|
4 |
C |
p. 65-69 |
artikel |
3 |
Cross-protective immunity induced by omicron variant of SARS-CoV-2
|
Chowdhury, Selia |
|
|
4 |
C |
p. 41-44 |
artikel |
4 |
Disseminated tuberculosis, CMV viraemia & haemophagocytic-lymphohistiocystosis syndrome in an adult patient with anti- IFNγ autoantibodies – case report and brief review
|
Butel-Simoes, G.I. |
|
|
4 |
C |
p. 55-59 |
artikel |
5 |
Editorial Board
|
|
|
|
4 |
C |
p. i |
artikel |
6 |
IL-23 Inhibitors to treat psoriatic arthritis: A systematic review & meta-analysis of randomized controlled trials
|
Vahidy, Ahmed Safi |
|
|
4 |
C |
p. 7-22 |
artikel |
7 |
Immune microenvironment and progress in immunotherapy of cholangiocarcinoma
|
Shao, Xinyu |
|
|
4 |
C |
p. 73-78 |
artikel |
8 |
Immunopathogenesis of cutaneous T-cell lymphoma in skin of color patients part 1: Mycosis fungoides
|
Desse, Sachi I. |
|
|
4 |
C |
p. 35-40 |
artikel |
9 |
Immunopathogenesis of cutaneous T-cell lymphoma in skin of color patients part 2: Sézary syndrome
|
Nwade, Nina C. |
|
|
4 |
C |
p. 30-34 |
artikel |
10 |
Novel approaches that promote lung endothelial and epithelial repair and anti pro inflammatory cytokines could be a future promising agent in the management of ARDS
|
Alrjoob, Montaser |
|
|
4 |
C |
p. 45-50 |
artikel |
11 |
Serum immunoglobulin levels and risk of antibiotic prescription in middle-aged and older individuals: A population-based cohort study
|
Vanoverschelde, Anna |
|
|
4 |
C |
p. 23-29 |
artikel |
12 |
Systemic lupus erythematosus in Latin America: Outcomes and therapeutic challenges
|
Ugarte-Gil, Manuel F. |
|
|
4 |
C |
p. 60-64 |
artikel |
13 |
TBE-antibody titer study: Is a booster already necessary after 5 years?
|
Mahlfleisch, Katharina |
|
|
4 |
C |
p. 70-72 |
artikel |
14 |
Time-series COVID-19 policy outcome analysis of the 50U.S. states
|
Takefuji, Yoshiyasu |
|
|
4 |
C |
p. 51-54 |
artikel |